https://www.selleckchem.com/products/gm6001.html
The surgery was completed with excellent hemostasis and no post-operative complications. Patients with FXI deficiency can successfully undergo conversion THA surgery; however, an individualized hematologic plan must be enacted to minimize complications and maximize surgical outcomes and patient satisfaction. This case demonstrates that the antifibrinolytic agents, aminocaproic acid and TXA, can be successfully used for hematologic prophylaxis in the perioperative period for this population of patients. Patients with FXI deficiency can su
Like
Comment
Share
